Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 11:32 AM UTC
| NCT Number | NCT06934915 |
| Recruiting Status | Recruiting |
| Condition | Autism Spectrum Disorder |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 32 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Christopher John McDougle, M.D. |
| Last Updated on CT.gov | August 19, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT06934915 is currently recruiting participants. This early_phase1 study for autism spectrum disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Christopher John McDougle, M.D.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06934915 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06934915 was last updated 1 week ago (August 19, 2026). HelloStudys verifies this status automatically.